MannKind Corp has a consensus price target of $7, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Cantor Fitzgerald, and HC Wainwright & Co. on March 15, 2024, February 28, 2024, and January 4, 2024. With an average price target of $6.83 between Cantor Fitzgerald, Cantor Fitzgerald, and HC Wainwright & Co., there's an implied 65.06% upside for MannKind Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/15/2024 | MNKD | Buy Now | MannKind | $4.14 | 57% | Cantor Fitzgerald | Olivia Brayer | → $6.5 | Reiterates | Overweight → Overweight | Get Alert |
02/28/2024 | MNKD | Buy Now | MannKind | $4.14 | 57% | Cantor Fitzgerald | Olivia Brayer | → $6.5 | Reiterates | Overweight → Overweight | Get Alert |
01/04/2024 | MNKD | Buy Now | MannKind | $4.14 | 81.16% | HC Wainwright & Co. | Oren Livnat | → $7.5 | Reiterates | Buy → Buy | Get Alert |
10/10/2023 | MNKD | Buy Now | MannKind | $4.14 | 141.55% | Wedbush | Andreas Argyrides | → $10 | Initiates | → Outperform | Get Alert |
08/14/2023 | MNKD | Buy Now | MannKind | $4.14 | 81.16% | HC Wainwright & Co. | Oren Livnat | $7 → $7.5 | Maintains | Buy | Get Alert |
08/08/2023 | MNKD | Buy Now | MannKind | $4.14 | 81.16% | Cantor Fitzgerald | Olivia Brayer | $6.5 → $7.5 | Maintains | Overweight | Get Alert |
05/11/2023 | MNKD | Buy Now | MannKind | $4.14 | 69.08% | HC Wainwright & Co. | Oren Livnat | → $7 | Reiterates | Buy → Buy | Get Alert |
02/27/2023 | MNKD | Buy Now | MannKind | $4.14 | 69.08% | HC Wainwright & Co. | Oren Livnat | $6 → $7 | Maintains | Buy | Get Alert |
11/09/2022 | MNKD | Buy Now | MannKind | $4.14 | 44.93% | SVB Leerink | Thomas Smith | $5 → $6 | Maintains | Outperform | Get Alert |
02/28/2022 | MNKD | Buy Now | MannKind | $4.14 | 44.93% | HC Wainwright & Co. | Oren Livnat | $6.5 → $6 | Maintains | Buy | Get Alert |
05/14/2021 | MNKD | Buy Now | MannKind | $4.14 | 20.77% | RBC Capital | Daniel Busby | — | Initiates | → Sector Perform | Get Alert |
The latest price target for MannKind (NASDAQ: MNKD) was reported by Cantor Fitzgerald on March 15, 2024. The analyst firm set a price target for $6.50 expecting MNKD to rise to within 12 months (a possible 57.00% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for MannKind (NASDAQ: MNKD) was provided by Cantor Fitzgerald, and MannKind reiterated their overweight rating.
There is no last upgrade for MannKind.
There is no last downgrade for MannKind.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MannKind, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MannKind was filed on March 15, 2024 so you should expect the next rating to be made available sometime around March 15, 2025.
While ratings are subjective and will change, the latest MannKind (MNKD) rating was a reiterated with a price target of $0.00 to $6.50. The current price MannKind (MNKD) is trading at is $4.14, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.